Maya Zeineddine is currently the Clinical Pharmacist of the Nehme and Therese Tohme Multiple Sclerosis Center at the American University of Beirut Medical Center (AUBMC). She graduated from the School of Pharmacy at the Lebanese American University (LAU) in 2010, passed the colloquium exam and joined the Lebanese Order of Pharmacists in August 2010. She was selected by LAU for the Doctor of Pharmacy program and was appointed in 2011 to do her clinical and ambulatory care rotations at Henry Ford Hospital and Karmanos Cancer Center, Detroit, Michigan. In June 2011, she completed her Doctor of Pharmacy program with distinction. She was also declared the winner of the “Best Clinician” and “Positive Attitude” awards in 2011 and has completed several internships at major hospital and community pharmacies in Lebanon and the US. In August 2015, she successfully passed the Multiple Sclerosis Specialization examination and became the first Multiple Sclerosis Certified Pharmacist in Lebanon and the Middle East.
Dr. Zeineddine is involved in several clinical trials, especially in the field of multiple sclerosis. She has ongoing and completed clinical research projects on teriflunomide in pediatrics, the use of fingolimod in clinical practice, the safety of fingolimod in pregnancy, the rate of anti-JCV virus antibody seroconversion in the Middle East, and the safety and efficacy of reduced fingolimod dosage treatment. She is a member of several national and international professional organizations including the American College of Clinical Pharmacy, the National Multiple Sclerosis Society of Lebanon, the National Multiple Sclerosis Society, and the Multiple Sclerosis Association of America. In December 2015, she was appointed as the Executive Secretary of the Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS).